Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 2

Patients treated with intravitreal triamcinolone acetonide [from Gallenga and Lobefalo] and Response to correspondence [from Kocabora]  ||FREE PAPER||

Authors Gallenga P, Lobefalo L

Published 6 June 2008 Volume 2008:2(2) Pages 483—484


Pier E Gallenga1, Lucio Lobefalo2

1University Eye Clinic, G.D’Annunzio University, Chieti, Italy; 2Ethical Committee, Italian Ophthalmological Society – SOI, Italy

The paper by Kocabora and coworkers (2008) underlines the message that patients treated with intravitreal triamcinolone acetonide are at risk of increased intraocular pressure (IOP) even after the clearance period of the drug. Furthermore, the development of intractable secondary glaucoma requiring surgical intervention is clear advice to monitor these patients carefully.


M Selim Kocabora

Vatan caddesi, Vakif Gureba Egitim ve Arastirma Hastanesi, Fatih, 34 000, Istanbul, Turkey.

We thank Dr. Gallenga and Dr. Lobefalo for their interest in our article (Kocabora et al 2008) and for their comments. We agree with them on the importance of pharmacovigilance and of warning the ophthalmology community about the potential risks of intravitreal triamcinolone (IVTA). We should always follow the principle of primum, non nocere in our medical practices. ...

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Collagen cross-linking: Strengthening the unstable cornea

Oren Tomkins, Hanna J Garzozi

Clinical Ophthalmology 2008, 2:863-867

Published Date: 5 December 2008

Sudden unilateral visual loss after autologous fat injection into the nasolabial fold

Sang Hyouk Park, Hae Jung Sun, Kyung Seek Choi

Clinical Ophthalmology 2008, 2:679-683

Published Date: 12 September 2008

Editorial: Clinical Ophthalmology and PubMed   ||Free paper||

Scott G Fraser

Clinical Ophthalmology 2008, 2:0-0

Published Date: 12 September 2008

Clinical experience with pegaptanib sodium

Chiara Rosina, Ferdinando Bottoni, Giovanni Staurenghi

Clinical Ophthalmology 2008, 2:485-488

Published Date: 12 September 2008

Epstein-Barr virus and acute retinal necrosis in a 5-year-old immunocompetent child

Roberto Gallego-Pinazo, Miguel Harto, Jose J Garcia-Medina, Inmaculada Serra, Enrique España, Maria D Pinazo-Duran

Clinical Ophthalmology 2008, 2:451-455

Published Date: 6 June 2008

Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors

Ziad F Bashshur, Abdallah M Terro, Christelle P El Haibi, Akaber M Halawi, Alexandre Schakal, Baha’ N Noureddin

Clinical Ophthalmology 2008, 2:269-274

Published Date: 6 June 2008

The challenge of dry eye diagnosis

Giacomo Savini, Pinita Prabhawasat, Takashi Kojima, Martin Grueterich, Edgar Espana, Eiki Goto

Clinical Ophthalmology 2008, 2:31-55

Published Date: 7 March 2008

Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology

Cleber A Trujillo, Arthur A Nery, Janaí­na M Alves, Antonio H Martins, Henning Ulrich

Clinical Ophthalmology 2007, 1:393-402

Published Date: 15 February 2008